New Lifetime High For Retrophin (RTRX)

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Trade-Ideas LLC identified Retrophin ( RTRX) as a new lifetime high candidate. In addition to specific proprietary factors, Trade-Ideas identified Retrophin as such a stock due to the following factors:

  • RTRX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $17.6 million.
  • RTRX has traded 44,412 shares today.
  • RTRX is trading at a new lifetime high.

EXCLUSIVE OFFER: Get the inside scoop on opportunities in RTRX with the Ticky from Trade-Ideas. See the FREE profile for RTRX NOW at Trade-Ideas

More details on RTRX:

Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. RTRX has a PE ratio of 116. Currently there are 2 analysts that rate Retrophin a buy, no analysts rate it a sell, and none rate it a hold.

The average volume for Retrophin has been 528,800 shares per day over the past 30 days. Retrophin has a market cap of $1.1 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.01 and a short float of 9.8% with 6.58 days to cover. Shares are up 164.7% year-to-date as of the close of trading on Wednesday.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you liked this article you might like

Martin Shkreli, "The Most Hated Man in America," Was Just Convicted on 3 Counts of Securities Fraud

First Witness to Testify in Pharma Bro's Trial Felt 'Betrayed'

Juror Selection In Martin Shkreli Case Drags Into a Third Day

First Amendment Needs to 'Take a Backseat' in Pharma Bro Trial: Lawyer

Potential Jurors Lambaste 'Pharma Bro' Shkreli as Judge Calls 180 People to Fill Just 18 Spots